Probability of antibody formation against circumsporozoite protein of Plasmodium vivax among Korean malaria patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
To evaluate the seroprevalence against circumsporozoite protein (CSP) of Plasmodium vivax in sera of Korean patients, the central repeating domain (CRD) of CSP was cloned and analyzed. From the genomic DNA of patient's blood, 2 kinds of CSPs were identified to belong to a VK210 type, which is the dominant repeating of GDRA(D/A)GQPA, and named as PvCSPA and PvCSPB. Recombinantly expressed his-tagged PvCSPA or PvCSPB in Escherichia coli reacted well against sera of patients in western blot, with the detecting rate of 47.9% (58/121), which included 15 cases positive for PvCSPA, 6 cases positive for PvCSPB, and 37 cases for both. The mixture of PvCSPA and PvCSPB was loaded to a rapid diagnostic test kit (RDT) and applied with the same set of patient sera, which resulted in detection rates of 57.0% (69/121). When the protein sequences of PvCSPA were compared with those of P. vivax in endemic regions of India and Uganda, they were compatibly homologous to PvCSPA with minor mutations. These results suggested that the recombinant PvCSPA and PvCSPB loaded RDT may be a milestone in latent diagnosis which has been a hot issue of domestic malaria and important for radical therapy in overlapped infections with P. falciparum in tropical and subtropical areas. During the biological process of malarial infection, exposure of CSP to antigen-antibody reaction up to 57.0% is the first report in Korea.
Abstract
To evaluate the seroprevalence against circumsporozoite protein (CSP) of Plasmodium vivax in sera of Korean patients, the central repeating domain (CRD) of CSP was cloned and analyzed. From the genomic DNA of patient's blood, 2 kinds of CSPs were identified to belong to a VK210 type, which is the dominant repeating of GDRA(D/A)GQPA, and named as PvCSPA and PvCSPB. Recombinantly expressed his-tagged PvCSPA or PvCSPB in Escherichia coli reacted well against sera of patients in western blot, with the detecting rate of 47.9% (58/121), which included 15 cases positive for PvCSPA, 6 cases positive for PvCSPB, and 37 cases for both. The mixture of PvCSPA and PvCSPB was loaded to a rapid diagnostic test kit (RDT) and applied with the same set of patient sera, which resulted in detection rates of 57.0% (69/121). When the protein sequences of PvCSPA were compared with those of P. vivax in endemic regions of India and Uganda, they were compatibly homologous to PvCSPA with minor mutations. These results suggested that the recombinant PvCSPA and PvCSPB loaded RDT may be a milestone in latent diagnosis which has been a hot issue of domestic malaria and important for radical therapy in overlapped infections with P. falciparum in tropical and subtropical areas. During the biological process of malarial infection, exposure of CSP to antigen-antibody reaction up to 57.0% is the first report in Korea.
참고문헌 (16)
- Chai, JY, "Re-emerging Plasmodium vivax malaria in the Republic of Korea", Korean J Parasitol, 37, pp.129~143 (1999)
- Lee JS, "Outbreak of vivax malaria in area adjacent to the demilitarized zone, South Korea", Am J Trop Med Hyg, 66, pp.13~17 (2002)
- Lee JS, "Current status of vivax malaria among civilians in Korea", Korean J Parasitol, 36, pp.241~248 (1998)
- Park JW, "Vivax malaria : a continuing health threat to the Republic of Korea", Am J Trop Med Hyg, 69, pp.159~167 (2003)
- Yeom JS, "Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003", Am J Trop Med Hyg, 73, pp.604~608 (2005)
- Yeom JS, "Plasmodium vivax malaria in the Republic of Korea during 2004-2005 : changing patterns of infection", Am J Trop Med Hyg, 76, pp.865~868 (2007)
- 한은택, "Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea", The Korean Journal of Parasitology, 44(4), pp.285~294 (2006), 대한기생충학ㆍ열대의학회
- Escalente AA, "Evolutionary origin of human and primate malarias : evidence from the circumsporozoite protein gene", Mol Biol Evol, 12, pp.616~626 (1995)
- Arnot DE, "Circumsporozoite protein of Plasmodium vivax : gene cloning and characterization of the immunodominant epitope", Science, 230, pp.815~818 (1985)
- Lim CS, "The analysis of circumsporozoites protein gene sequences from Plasmodium vivax isolates in the Republic of Korea", Ann Trop Med parasitol, 95, pp.229~235 (2001)
- Kim T, "The molecular characteristics of circumsporozoite protein gene subtype from Plasmodium vivax isolates in Republic of Korea", Parasitol Res, 88, pp.1051~1054 (2002)
- 송경주, "A Rapid Diagnostic Test for Toxoplasmosis using Recombinant Antigenic N-terminal Half of SAG1 Linked with Intrinsically Unstructured Domain of GRA2 Protein", The Korean Journal of Parasitology, 51(5), pp.503~510 (2013), 대한기생충학ㆍ열대의학회
- Lee HW, "DNA sequencing and expression of the circumsporozoite protein of Plasmodium vivax Korean isolate in Escherichia coli", Korean J Microbiol, 37, pp.234~242 (1999)
- SeraKIM, "ELISA detection of vivax malaria with recombinant multiple stage-specific antigens and its application to survey of residents in endemic areas", The Korean Journal of Parasitology, 41(4), pp.203~207 (2003), 대한기생충학ㆍ열대의학회
- Arnot DE, "Does biased gene conversion influence polymorphism in the circumsporozoite protein-encoding gene of Plasmodium vivax?", Proc Natl Acad Sci USA, 85, pp.8102~8106 (1988)
- Ntumngia FB, "Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development", Am J Trop Med Hyg, 80, pp.218~227 (2009)